Cell Design Labs
United States · $34.4M raised
- Headquarters
- California
- Business Model
- B2B
- Total Funding
- $34.4M
- Last Round
- $34.4M Series AJun 2016
- Rounds
- 1
About
Biotechnology company developing novel cell-based therapies for cancer treatment; acquired by Gilead Sciences for up to $567M.
Summary
Cell Design Labs is a Biotech company based in United States. It has raised $34.4M in total across 1 round, most recently a $34.4M Series A round in Jun 2016. Investors include Kleiner Perkins, Mission Bay Capital and Bellco Capital.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2016
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...